These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1720 related items for PubMed ID: 8490470

  • 1. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O.
    BMJ; 1993 Apr 10; 306(6883):956-63. PubMed ID: 8490470
    [Abstract] [Full Text] [Related]

  • 2. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
    Lidegaard O.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3538-45. PubMed ID: 8236574
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 01; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 9. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M, Mann J, Murphy M, Vessey M.
    Int J Epidemiol; 1992 Feb 06; 21(1):48-52. PubMed ID: 1544757
    [Abstract] [Full Text] [Related]

  • 15. On the epidemiology of oral contraceptives and disease.
    Prentice RL, Thomas DB.
    Adv Cancer Res; 1987 Feb 06; 49():285-401. PubMed ID: 3314396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G, Kohlmeier L, Brenner H.
    Eur J Clin Nutr; 1998 Oct 06; 52(10):711-5. PubMed ID: 9805216
    [Abstract] [Full Text] [Related]

  • 18. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD, Lawrenson RA.
    Am J Obstet Gynecol; 1998 Sep 16; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP, Encarnacion CE, Chintapalli KN, Rees CR.
    J Am Board Fam Pract; 1997 Sep 16; 10(5):315-21. PubMed ID: 9297655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.